Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.4B | 2.8B | 2.2B | 2.0B |
Cost of revenue | 1.2B | 1.5B | 1.0B | 1B |
Gross profit | 1.2B | 1.4B | 1.1B | 1.0B |
Operating expense | ||||
Research & development | 377M | 351M | 332M | 349M |
Selling general and admin | 514M | 460M | 445M | 413M |
Other operating expenses | 75M | 76M | 58M | 42M |
Operating income | 203M | 465M | 283M | 241M |
Non operating interest income | ||||
Income | 65M | 72M | 77M | 80M |
Expense | — | — | — | — |
Other income expense | -1.0B | 884M | 500M | -118M |
Pretax income | -770M | 1.4B | 860M | 203M |
Tax provision | -88M | 128M | 32M | 32M |
Net income | -682M | 1.3B | 828M | 171M |
Basic EPS | 0.0 | 0.0 | 0.0 | 0.0 |
Diluted EPS | 0.0 | 0.0 | 0.0 | 0.0 |
Basic average shares | 27.4B | 27.3B | 27.3B | 27.2B |
Diluted average shares | 27.4B | 27.3B | 27.5B | 27.4B |
EBITDA | 1.2B | -433M | -237M | 369M |
Net income from continuing op. | -682M | 1.3B | 828M | 171M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |